Organon & Co | Capital Ordinaire



Ordinary Share Capital Changement Date
Adcock Ingram Holdings ZAR 14.68M 427K 2024-06
Bristol-Myers Squibb USD 292M 0 2024-12
Celltrion KRW 220.45B 27.97M 2024-09
Cspc Pharmaceutical CNY 11.01B 106.43M 2024-06
Dianthus Therapeutics USD 29K 0 2024-09
Ecofibre AUD 120.81M 134K 2024-06
Gilead Sciences USD 1000K 0 2024-12
Glaxosmithkline GBP 1.35B 0 2024-12
Kangmei Pharma CNY 13.86B 0 2024-09
Knight Therapeutics CAD 539.32M 1.63M 2024-09
Laboratorios Farma EUR 3.24M 0 2023-06
Malin Corporation EUR 200K 0 2024-06
Medical Developments International AUD 105.73M 0 2024-06
Merck USD 1.79B 0 2024-12
Neuren Pharmaceuticals AUD 165.27M 10.43M 2024-12
Novartis USD 793M 0 2024-12
Organigram Holdings CAD 892.59M 39.7M 2024-12
Organon & Co USD 3M 0 2024-09
Pharma Mar EUR 10.93M 80K 2024-12
Qiagen NV USD 2.6M 0 2024-09
Sartorius EUR 69M 600K 2024-09
Sino Biopharmaceutical CNY 414.38M 231K 2024-06
Tilray USD 93K 5K 2024-11



Organon & Co Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.